OverviewSuggest Edit

Harrow Health (formerly Imprimis Pharmaceuticals) is a pharmaceutical company dedicated to delivering high quality and innovative medicines to physicians and patients at accessible prices. The Company operates through the business of developing drug therapies and providing such therapies through sterile and non-sterile pharmaceutical compounding services segment. It also owns, markets and dispenses a portfolio of compounded therapeutic in several therapeutic areas, including ophthalmology, urology, otolaryngology and infectious diseases.

TypePublic
Founded2012
HQSan Diego, US
Websiteharrowinc.com

Latest Updates

Employees (est.) (Mar 2019)134(+5%)
Job Openings12
Revenue (FY, 2018)$41.4 M(+55%)
Share Price (Jun 2019)$5.6 (-2%)

Key People/Management at Harrow Health

Mark L. Baum

Mark L. Baum

Chief Executive Officer, Member, Board of Directors
Andrew R. Boll

Andrew R. Boll

CFO
John Saharek

John Saharek

Chief Commercial Officer
Show more

Harrow Health Office Locations

Harrow Health has offices in San Diego, Roxbury Township and Irvine
San Diego, US (HQ)
12264 El Camino Real #350
Irvine, US
9257 Research Dr
Roxbury Township, US
1705 US-46 #6b, Ledgewood
Show all (3)

Harrow Health Financials and Metrics

Harrow Health Revenue

Harrow Health's revenue was reported to be $41.37 m in FY, 2018
USD

Revenue (Q2, 2019)

13.5m

Gross profit (Q2, 2019)

8.3m

Gross profit margin (Q2, 2019), %

61.3%

EBIT (Q2, 2019)

(767.0k)

Market capitalization (10-Jun-2019)

138.9m

Closing stock price (10-Jun-2019)

5.6
Harrow Health's current market capitalization is $138.9 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

1.7m9.7m19.9m26.8m41.4m

Revenue growth, %

485%105%

Cost of goods sold

1.1m5.2m9.8m13.5m16.5m

Gross profit

567.4k4.5m10.1m13.3m24.9m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

667.7k441.0k1.6m2.0m2.7m4.4m4.9m4.9m6.1m6.9m6.5m8.9m10.4m10.7m12.3m13.5m

Cost of goods sold

239.0k1.0m1.1m1.2m2.2m2.2m2.3m3.4m3.3m3.4m4.1m4.2m4.2m3.9m5.2m

Gross profit

202.1k556.0k917.0k1.5m2.1m2.7m2.5m2.7m3.6m3.1m4.8m6.2m6.5m8.4m8.3m

Gross profit Margin, %

46%36%47%55%49%56%52%45%52%48%54%60%61%68%61%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

15.6m8.2m2.7m8.9m4.0m

Accounts Receivable

81.3k840.0k2.9m1.5m1.9m

Inventories

105.1k372.7k1.4m1.8m2.2m1.8m

Current Assets

15.7m9.1m5.9m14.8m8.8m32.8m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Cash

16.8m14.2m12.1m10.4m2.9m10.1m6.6m11.8m5.4m2.4m7.4m4.2m3.9m

Accounts Receivable

1.4k81.1k68.3k436.0k579.0k701.0k943.0k1.9m2.2m3.0m2.9m2.6m1.5m1.4m1.7m2.2m2.2m

Inventories

172.8k351.2k711.0k793.0k1.3m1.2m1.4m1.9m2.0m1.8m2.4m2.0m2.2m2.5m2.4m2.7m

Current Assets

17.4m14.4m12.8m11.3m4.6m12.0m9.4m14.9m9.4m9.0m13.6m10.4m10.1m7.4m8.7m11.7m38.5m38.1m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(7.6m)(10.1m)(15.9m)(19.1m)(12.0m)14.6m

Depreciation and Amortization

5.7k

Inventories

(17.0k)(159.5k)(314.0k)(429.0k)(821.0k)415.0k

Accounts Payable

(239.8k)345.4k1.0m1.5m346.0k2.4m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Net Income

(5.8m)(2.3m)(4.9m)(7.4m)(3.1m)(6.8m)(10.8m)(4.5m)(9.1m)(13.0m)(5.0m)(3.5m)(9.2m)(3.5m)(991.0k)(3.5m)11.4m8.9m

Depreciation and Amortization

3.5k2.6k

Inventories

40.4k(138.0k)711.0k(188.0k)(605.0k)179.0k(29.0k)(490.0k)(203.0k)(404.0k)(946.0k)209.0k33.0k(275.0k)(554.0k)(818.0k)

Accounts Payable

229.6k145.2k318.1k372.2k1.1m121.0k845.0k996.0k1.6m1.6m364.0k(194.0k)497.0k106.0k885.0k2.2m
USDY, 2019

Financial Leverage

1.9 x
Show all financial metrics

Harrow Health Online and Social Media Presence

Embed Graph

Harrow Health News and Updates

Harrow Health to Attend Lake Street’s 3rd Annual Best Ideas Growth Conference September 12, 2019

NASHVILLE, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that it will be attending Lake Street’s 3rd Annual BIG Conference September 12, 2019.

Harrow Health Adds Two Senior Executives to its Nashville Team

NASHVILLE, Tenn., June 25, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that it has promoted Dennis Saadeh, PharmD as its Chief of Formulation Strategy and has hired Larry Dillaha, MD as its Chief Medical Officer.  Dr. Saadeh, who is a 30-year veteran of pharmaceutic…

Harrow Health, Inc to Locate Headquarters in Nashville, Tennessee

NASHVILLE, Tenn., June 18, 2019 (GLOBE NEWSWIRE) -- Tennessee Governor, Bill Lee, Department of Economic and Community Development Commissioner Bob Rolfe and Harrow Health, Inc (NASDAQ: HROW) announced today that the company will locate its headquarters operations in Nashville.

Novel Drug Solutions, LLC and Eye Care Northwest, PA Terminates Agreement with Harrow Health, Inc.

ROSELAND, N.J., May 30, 2019 /PRNewswire/ -- Axiom Communications, on behalf of Novel Drug Solutions, LLC and Eye Care Northwest, PA announced today that the companies have delivered a Notice of Termination and Cease and Desist directive to Harrow Health, Inc. (NASDAQ: HROW formerly known ...

Imprimis Pharmaceuticals, Inc. Completes Name Change to Harrow Health, Inc.

Harrow Health, Inc. Name Reflects the Company’s Commitment to the Future of Healthcare Harrow Health, Inc. Name Reflects the Company’s Commitment to the Future of Healthcare

Imprimis Pharmaceuticals Announces Third Quarter 2018 Results

SAN DIEGO, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) today reported results for the third quarter 2018.
Show more

Harrow Health Blogs

Harrow Health Announces Second Quarter 2019 Results

Harrow Health Announces Second Quarter 2019 Results

Harrow Health Forms Stowe Pharmaceuticals Subsidiary to Develop Broad Spectrum Anti-Microbial Ophthalmic and Otic Therapeutics

Harrow Health Forms Stowe Pharmaceuticals Subsidiary to Develop Broad Spectrum Anti-Microbial Ophthalmic and Otic Therapeutics

Harrow Health Announces Launch of Mayfield Pharmaceuticals

Harrow Health Announces Launch of Mayfield Pharmaceuticals

Harrow Health to Announce Second Quarter 2019 Financial Results on August 14, 2019

Harrow Health to Announce Second Quarter 2019 Financial Results on August 14, 2019

Analysis: Positioning to Benefit within Abeona Therapeutics, Great Lakes Dredge & Dock, Imprimis Pharmaceuticals, Alliant Energy, Cytokinetics, and Aurinia Pharmaceuticals — Research Highlights Growth, Revenue, and Consolidated Results

Analysis: Positioning to Benefit within Abeona Therapeutics, Great Lakes Dredge & Dock, Imprimis Pharmaceuticals, Alliant Energy, Cytokinetics, and Aurinia Pharmaceuticals — Research Highlights Growth, Revenue, and Consolidated Results

Imprimis Pharmaceuticals Ranked 88th Fastest Growing Company in North America on Deloitte’s 2018 Technology Fast 500™

Imprimis Pharmaceuticals Ranked 88th Fastest Growing Company in North America on Deloitte’s 2018 Technology Fast 500™
Show more

Harrow Health Frequently Asked Questions

  • When was Harrow Health founded?

    Harrow Health was founded in 2012.

  • Who are Harrow Health key executives?

    Harrow Health's key executives are Mark L. Baum, Andrew R. Boll and John Saharek.

  • How many employees does Harrow Health have?

    Harrow Health has 134 employees.

  • What is Harrow Health revenue?

    Latest Harrow Health annual revenue is $41.4 m.

  • What is Harrow Health revenue per employee?

    Latest Harrow Health revenue per employee is $308.7 k.

  • Who are Harrow Health competitors?

    Competitors of Harrow Health include Hemogenyx Pharmaceuticals, India Globalization Capital and Tarveda Therapeutics.

  • Where is Harrow Health headquarters?

    Harrow Health headquarters is located at 12264 El Camino Real #350, San Diego.

  • Where are Harrow Health offices?

    Harrow Health has offices in San Diego, Roxbury Township and Irvine.

  • How many offices does Harrow Health have?

    Harrow Health has 3 offices.